Florida Takes Action Against Abortion Pill Marketing
TALLAHASSEE, Fla. – Florida’s Attorney General, James Uthmeier, is challenging claims about the safety of a drug used in medical abortions, saying it’s wrong to suggest it’s “safer than Tylenol.” He has launched a legal effort, citing concerns about the well-being of women and questioning the marketing practices surrounding the drug.
Mifepristone, a drug that blocks a hormone needed to maintain a pregnancy, is used in a two-step process to end a pregnancy. The second drug causes contractions to expel the unborn child. The FDA allows mifepristone to be used up to 10 weeks into a pregnancy.
Uthmeier argues that there’s growing evidence of negative health effects for women who use mifepristone. He pointed to studies suggesting that complications from the drug have led to deaths.
The legal action aims to address what the Attorney General sees as misleading claims that put women at risk. The state argues that Planned Parenthood is aware that the “safer than Tylenol” claims are false and that they mislead women about the real dangers of chemical abortions. The state also noted women who use these drugs often end up in the emergency room with serious problems.
The lawsuit also alleges that Planned Parenthood may prefer chemical abortions over surgical procedures for financial reasons. The lawsuit says Planned Parenthood’s business is booming and attributes its success to decreasing unprofitable health services and increasing abortions.
The lawsuit accuses Planned Parenthood of violating laws usually used to combat organized crime, arguing that their advertising of mifepristone’s safety is a pattern of illegal activity.
Planned Parenthood has defended the safety of mifepristone and said they provide accurate information to their patients.
